In the last years, identification of inherited defects in the ASC-1 complex and their association with monogenic congenital neuromuscular disease has represented a significant progress in the molecular characterization of these rare disorders, and revealed defects in co-transcriptional regulation, cell cycle and cell growth as novel pathomechanisms. The gene discussed is TRIP4; the disease is neuromuscular disease.